• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma.

作者信息

Evers Marietheres, Schreder Martin, Stühmer Thorsten, Jundt Franziska, Ebert Regina, Hartmann Tanja Nicole, Altenbuchinger Michael, Rudelius Martina, Kuric Martin, Rindt Wyonna Darleen, Steinbrunn Torsten, Langer Christian, Heredia-Guerrero Sofia Catalina, Einsele Hermann, Bargou Ralf Christian, Rosenwald Andreas, Leich Ellen

机构信息

Institute of Pathology, University of Würzburg, Würzburg, Germany.

Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.

出版信息

Blood Cancer J. 2023 Mar 23;13(1):43. doi: 10.1038/s41408-023-00817-7.

DOI:10.1038/s41408-023-00817-7
PMID:36959208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10036560/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb5/10036560/4220e0695a0b/41408_2023_817_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb5/10036560/6d1f154182f7/41408_2023_817_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb5/10036560/4220e0695a0b/41408_2023_817_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb5/10036560/6d1f154182f7/41408_2023_817_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cb5/10036560/4220e0695a0b/41408_2023_817_Fig2_HTML.jpg

相似文献

1
Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma.细胞外基质基因突变及表达在多发性骨髓瘤中的预后价值
Blood Cancer J. 2023 Mar 23;13(1):43. doi: 10.1038/s41408-023-00817-7.
2
Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.人多发性骨髓瘤骨髓细胞外基质的蛋白质组学特性研究
Leukemia. 2017 Nov;31(11):2426-2434. doi: 10.1038/leu.2017.102. Epub 2017 Mar 27.
3
Immunohistochemical expression of cell cycle proteins in multiple myeloma.多发性骨髓瘤中细胞周期蛋白的免疫组化表达
Leuk Lymphoma. 2015;56(9):2720-3. doi: 10.3109/10428194.2015.1004171. Epub 2015 Feb 4.
4
Plasma cell myeloma with histiocyte-like morphology.具有组织细胞样形态的浆细胞骨髓瘤。
Int J Hematol. 2017 Sep;106(3):307-309. doi: 10.1007/s12185-017-2249-6. Epub 2017 May 29.
5
[Morphological diagnosis of plasmocytic myeloma in trephine biopsy (histological and immunohistochemical criteria)].[骨髓活检中浆细胞骨髓瘤的形态学诊断（组织学和免疫组织化学标准）]
Arkh Patol. 2007 Mar-Apr;69(2):50-2.
6
Relationship of P-selectin glycoprotein ligand-1 to prognosis in patients with multiple myeloma.P-选择素糖蛋白配体-1与多发性骨髓瘤患者预后的关系
Clin Lymphoma Myeloma Leuk. 2015 Mar;15(3):164-70. doi: 10.1016/j.clml.2014.09.005. Epub 2014 Sep 28.
7
Bone marrow trephine biopsy findings in myeloma with small-lymphoid cells and CCND1 translocation.伴有小淋巴细胞及CCND1易位的骨髓瘤的骨髓环钻活检结果
Am J Hematol. 2011 Dec;86(12):1038. doi: 10.1002/ajh.22128. Epub 2011 Sep 2.
8
Diagnosis and risk stratification in multiple myeloma.多发性骨髓瘤的诊断与风险分层
Hematol Oncol Clin North Am. 2014 Oct;28(5):791-813. doi: 10.1016/j.hoc.2014.06.007. Epub 2014 Jul 22.
9
Extracellular matrix in bone marrow can mediate drug resistance in myeloma.骨髓中的细胞外基质可介导骨髓瘤的耐药性。
Leuk Lymphoma. 2005 Jun;46(6):803-11. doi: 10.1080/10428190500051448.
10
Nonsynthetizing multiple myeloma.非合成性多发性骨髓瘤
Haematologia (Budap). 1977;11(1-2):73-7.

引用本文的文献

1
Proteomic Analysis of Bone Marrow CD138+ Cells to Identify Proteins Associated With the Response of Multiple Myeloma Patients to Commonly Used Therapeutic Regimens.对骨髓CD138+细胞进行蛋白质组学分析，以鉴定与多发性骨髓瘤患者对常用治疗方案反应相关的蛋白质。
Proteomics. 2025 Aug;25(16):48-60. doi: 10.1002/pmic.70025. Epub 2025 Aug 7.
2
Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myeloma.血液来源的游离DNA是多发性骨髓瘤无创DNA甲基化分析的一种优良生物标志物。
Blood Adv. 2025 Aug 26;9(16):4306-4310. doi: 10.1182/bloodadvances.2025016480.
3
Deep hematologic response to RD treatment in patients with multiple myeloma is associated with overexpression of IL-17R in CD138+ plasma cells.

本文引用的文献

1
Adhesion molecules in multiple myeloma oncogenesis and targeted therapy.黏附分子在多发性骨髓瘤发生发展及靶向治疗中的作用
Int J Hematol Oncol. 2022 Apr 26;11(2):IJH39. doi: 10.2217/ijh-2021-0017. eCollection 2022 Apr.
2
O-GlcNAcylation homeostasis controlled by calcium influx channels regulates multiple myeloma dissemination.钙流入通道调控的 O-GlcNAc 化平衡控制多发性骨髓瘤的扩散。
J Exp Clin Cancer Res. 2021 Mar 16;40(1):100. doi: 10.1186/s13046-021-01876-z.
3
Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma.
在多发性骨髓瘤患者中，对 RD 治疗的深度血液学反应与 CD138+浆细胞中 IL-17R 的过度表达有关。
Sci Rep. 2024 Oct 9;14(1):23559. doi: 10.1038/s41598-024-74558-3.
4
Association of ADAM family members with proliferation signaling and disease progression in multiple myeloma.ADAM 家族成员与多发性骨髓瘤中增殖信号和疾病进展的关联。
Blood Cancer J. 2024 Sep 11;14(1):156. doi: 10.1038/s41408-024-01133-4.
5
Biobanks in chronic disease management: A comprehensive review of strategies, challenges, and future directions.慢性病管理中的生物样本库：策略、挑战及未来方向的全面综述
Heliyon. 2024 May 28;10(11):e32063. doi: 10.1016/j.heliyon.2024.e32063. eCollection 2024 Jun 15.
6
Pan-Cancer Single-Nucleus Total RNA Sequencing Using snHH-Seq.基于 snHH-Seq 的泛癌种单细胞全长 RNA 测序。
Adv Sci (Weinh). 2024 Feb;11(5):e2304755. doi: 10.1002/advs.202304755. Epub 2023 Nov 27.
7
The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature.细胞外基质分子与免疫检查点抑制剂在癌症中的相互作用：文献系统综述。
Front Immunol. 2023 Oct 3;14:1270981. doi: 10.3389/fimmu.2023.1270981. eCollection 2023.
多发性骨髓瘤中受体酪氨酸激酶和黏附信号传导背景下的新型分子亚群。
Blood Cancer J. 2021 Mar 4;11(3):51. doi: 10.1038/s41408-021-00442-2.
4
Upregulated expression and function of the α4β1 integrin in multiple myeloma cells resistant to bortezomib.多发性骨髓瘤细胞对硼替佐米耐药中α4β1 整合素的表达和功能上调。
J Pathol. 2020 Sep;252(1):29-40. doi: 10.1002/path.5480. Epub 2020 Jul 22.
5
The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma.肿瘤异质性对多发性骨髓瘤的诊断和新型治疗策略的影响。
Int J Mol Sci. 2019 Mar 12;20(5):1248. doi: 10.3390/ijms20051248.
6
The activated conformation of integrin β is a novel multiple myeloma-specific target for CAR T cell therapy.整合素 β 的激活构象是 CAR T 细胞治疗多发性骨髓瘤的新型特异性靶点。
Nat Med. 2017 Dec;23(12):1436-1443. doi: 10.1038/nm.4431. Epub 2017 Nov 6.
7
The ADAMs family of proteases as targets for the treatment of cancer.作为癌症治疗靶点的ADAMs蛋白酶家族。
Cancer Biol Ther. 2016 Aug 2;17(8):870-80. doi: 10.1080/15384047.2016.1177684. Epub 2016 Apr 26.
8
Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules.多发性骨髓瘤受黏附及受体酪氨酸激酶信号分子的多种和异质性体细胞突变的影响。
Blood Cancer J. 2013 Feb 8;3(2):e102. doi: 10.1038/bcj.2012.47.
9
Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion.整合素β7 介导的多发性骨髓瘤细胞黏附、迁移和侵袭的调控。
Blood. 2011 Jun 9;117(23):6202-13. doi: 10.1182/blood-2010-06-292243. Epub 2011 Apr 7.
10
Adhesion molecules--The lifelines of multiple myeloma cells.黏附分子——多发性骨髓瘤细胞的生命线。
Semin Cancer Biol. 2010 Jun;20(3):186-95. doi: 10.1016/j.semcancer.2010.04.003. Epub 2010 Apr 21.